Last reviewed · How we verify

NCT02368275

Genetic, Neurophysiological and Psychological Risk Factors for Neuropathic Pain

Completed Last updated 30 April 2021
What this trial tests

trial in Surgery in 250 participants. Completed in 30 September 2020.

Timeline
1 March 2017
Primary endpoint
30 July 2020
30 September 2020

Quick facts

Lead sponsorHospital Ambroise Paré Paris
StatusCompleted
Study typeOBSERVATIONAL
Enrollment250
Start date1 March 2017
Primary completion30 July 2020
Estimated completion30 September 2020
Sites2 locations across France

Conditions studied

Sponsor

Hospital Ambroise Paré Paris

Who can join

18 and older, any sex, with Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of these cohorts is to detect potential genetic, neurophysiological psychological and cognitive risk factors for the development of chronic postsurgical pain including neuropathic pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Somatic and psychological predictors of chronic postsurgical pain in cancer patients: a machine learning approach in a longitudinal two-centre study.
    Sperandio G, Baudic S, Bennedsgaard K, Grosen K, et al · · 2026 · cited 2× · PMID 41506969 · DOI 10.1016/j.bja.2025.12.002

Verify or expand the search:

Other recruiting trials for Surgery

Currently open trials in the same condition.

Other Hospital Ambroise Paré Paris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02368275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing